Sanctuary Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$681K Buy
14,407
+8,117
+129% +$417K ﹤0.01% 1741
2026
Q1
$373K Sell
6,290
-570
-8% -$37K ﹤0.01% 1959
2025
Q4
$423K Sell
6,860
-951
-12% -$58.2K ﹤0.01% 1825
2025
Q3
$487K Buy
7,811
+1,828
+31% +$127K ﹤0.01% 1732
2025
Q2
$478K Sell
5,983
-137
-2% -$11.5K ﹤0.01% 1659
2025
Q1
$526K Sell
6,120
-12,055
-66% -$989K ﹤0.01% 1494
2024
Q4
$1.43M Buy
18,175
+927
+5% +$72K 0.01% 1050
2024
Q3
$1.46M Buy
17,248
+1,715
+11% +$121K 0.01% 1058
2024
Q2
$1.09M Buy
+15,533
New +$1.05M 0.01% 1151

Other funds holding PBH

Sanctuary Advisors's PBH Position: Q2 2026 in Review

Sanctuary Advisors increased its Prestige Consumer Healthcare (PBH) stake by 129% in Q2 2026, buying an estimated $417K and bringing the position to 14,407 shares worth $681K. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Sanctuary Advisors first reported a position in PBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.46M in Q3 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Sanctuary Advisors held 14,407 shares of Prestige Consumer Healthcare worth $681K as of Q2 2026.
  • Sanctuary Advisors bought 8,117 Prestige Consumer Healthcare shares in Q2 2026, an estimated $417K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1741 holding.
  • Sanctuary Advisors first reported a position in Prestige Consumer Healthcare in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Prestige Consumer Healthcare position peaked at $1.46M in Q3 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.